首页> 外文期刊>Reproductive Health >Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial
【24h】

Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial

机译:降低访问和围产期死亡率的产前护理包装:对世卫组织产前护理试验的二级分析

获取原文
           

摘要

Background In 2001, the WHO Antenatal Care Trial (WHOACT) concluded that an antenatal care package of evidence-based screening, therapeutic interventions and education across four antenatal visits for low-risk women was not inferior to standard antenatal care and may reduce cost. However, an updated Cochrane review in 2010 identified an increased risk of perinatal mortality of borderline statistical significance in three cluster-randomized trials (including the WHOACT) in developing countries. We conducted a secondary analysis of the WHOACT data to determine the relationship between the reduced visits, goal-oriented antenatal care package and perinatal mortality. Methods Exploratory analyses were conducted to assess the effect of baseline risk and timing of perinatal death. Women were stratified by baseline risk to assess differences between intervention and control groups. We used linear modeling and Poisson regression to determine the relative risk of fetal death, neonatal death and perinatal mortality by gestational age. Results 12,568 women attended the 27 intervention clinics and 11,958 women attended the 26 control clinics. 6,160 women were high risk and 18,365 women were low risk. There were 161 fetal deaths (1.4%) in the intervention group compared to 119 fetal deaths in the control group (1.1%) with an increased overall adjusted relative risk of fetal death (Adjusted RR 1.27; 95% CI 1.03, 1.58). This was attributable to an increased relative risk of fetal death between 32 and 36?weeks of gestation (Adjusted RR 2.24; 95% CI 1.42, 3.53) which was statistically significant for high and low risk groups. Conclusion It is plausible the increased risk of fetal death between 32 and 36?weeks gestation could be due to reduced number of visits, however heterogeneity in study populations or differences in quality of care and timing of visits could also be playing a role. Monitoring maternal, fetal and neonatal outcomes when implementing antenatal care protocols is essential. Implementing reduced visit antenatal care packages demands careful monitoring of maternal and perinatal outcomes, especially fetal death.
机译:背景技术在2001年,世卫组织产蛋治疗审判(BAHACT)的结论是,在低危妇女的四个产前访问的基于证据的筛查,治疗干预和教育的产前保健包并不逊于标准产前护理,并可能降低成本。然而,2010年更新的Cochrane审查确定了在发展中国家的三次组合 - 随机试验(包括BONACT)中围产期统计显着性的围产期死亡率的风险增加。我们对DHOACT数据进行了次要分析,以确定降低的访问,面向目标的产前护理包和围产期死亡率之间的关系。方法进行探索性分析,以评估基线风险和围产期死亡时机的影响。妇女通过基线风险分层,以评估干预和对照组之间的差异。我们使用线性建模和泊松回归来确定胎儿死亡,新生儿死亡和围产期死亡率的相对风险。结果12,568名妇女参加了27名干预诊所,11,958名妇女参加了26名控制诊所。 6,160名女性患有高风险,18,365名女性风险低。干预组中有161例胎儿死亡(1.4%)与对照组的119例胎儿死亡(1.1%)相比,胎儿死亡的整体调整后的相对风险增加(调整为1.27; 95%CI 1.03,1.58)。这归因于胎儿死亡的相对风险增加32至36次?妊娠周(调整后的RR 2.24; 95%CI 1.42,3.53),对于高风险群体具有统计学意义。结论胎儿死亡风险增加32至36岁以下的妊娠可能是由于缩小的访问数量,然而,研究人口或差异质量的差异和访问时机的异质性也可能发挥作用。在实施产前护理方案时监测母体,胎儿和新生儿结果至关重要。实施减少的访问产前护理包裹要求仔细监测母体和围产期结果,尤其是胎儿死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号